Regulatory mechanisms of tau protein fibrillation under the conditions of liquid-liquid phase separation
- 15 December 2020
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 117 (50), 31882-31890
- https://doi.org/10.1073/pnas.2012460117
Abstract
One of the hallmarks of Alzheimer's disease and several other neurodegenerative disorders is the aggregation of tau protein into fibrillar structures. Building on recent reports that tau readily undergoes liquid-liquid phase separation (LLPS), here we explored the relationship between disease-related mutations, LLPS, and tau fibrillation. Our data demonstrate that, in contrast to previous suggestions, pathogenic mutations within the pseudorepeat region do not affect tau441's propensity to form liquid droplets. LLPS does, however, greatly accelerate formation of fibrillar aggregates, and this effect is especially dramatic for tau441 variants with disease-related mutations. Most important, this study also reveals a previously unrecognized mechanism by which LLPS can regulate the rate of fibrillation in mixtures containing tau isoforms with different aggregation propensities. This regulation results from unique properties of proteins under LLPS conditions, where total concentration of all tau variants in the condensed phase is constant. Therefore, the presence of increasing proportions of the slowly aggregating tau isoform gradually lowers the concentration of the isoform with high aggregation propensity, reducing the rate of its fibrillation. This regulatory mechanism may be of direct relevance to phenotypic variability of tauopathies, as the ratios of fast and slowly aggregating tau isoforms in brain varies substantially in different diseases.Keywords
Funding Information
- HHS | NIH | National Institute on Aging (RF1 AG061797)
- HHS | NIH | NIH Office of the Director (OD024996)
This publication has 50 references indexed in Scilit:
- FTDP-17 Tau Mutations Induce Distinct Effects on Aggregation and Microtubule InteractionsBiochemistry, 2012
- Tau Isoform Composition Influences Rate and Extent of Filament FormationPublished by Elsevier BV ,2012
- Biochemistry and Cell Biology of Tau Protein in Neurofibrillary DegenerationCold Spring Harbor Perspectives in Medicine, 2012
- Structural Polymorphism of 441-Residue Tau at Single Residue ResolutionPLoS Biology, 2009
- The Kinetics of Nucleated Polymerizations at High Concentrations: Amyloid Fibril Formation Near and Above the “Supercritical Concentration”Biophysical Journal, 2006
- Structure, Microtubule Interactions, and Paired Helical Filament Aggregation by Tau Mutants of Frontotemporal DementiasBiochemistry, 2000
- Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif ( 306 VQIVYK 311 ) forming β structureProceedings of the National Academy of Sciences of the United States of America, 2000
- [17] Analysis of protein aggregation kineticsMethods in Enzymology, 1999
- Abnormal Tau proteins in progressive supranuclear palsyActa Neuropathologica, 1991
- Straight and paired helical filaments in Alzheimer disease have a common structural unit.Proceedings of the National Academy of Sciences of the United States of America, 1991